RHHBY Roche Holding AG Loading...

From LH earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
13:00
Jul 30 ◎
Adam Schechter CEO, Labcorp Holdings Inc. LH Q2 FY26 call
Partnership to expand access to Roche's companion diagnostic; impacts prostate cancer treatment.
RHHBY
HIGH
14:00
Feb 17 ◎
Adam Schechter CEO, Labcorp Holdings Inc. LH Q4 FY25 call
Company installed new automated mass spectrometry system from Roche Diagnostics, signaling capex spend and automation shift. — This could provide Roche with a flagship reference site and competitive edge in lab automation, signaling potential share gains for Roche's diagnostics segment.
RHHBY
MED

About RHHBY Analyst Coverage

Buzzberg tracks RHHBY (Roche Holding AG) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Adam Schechter.